SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS ARTICLE H impact

$ABT Abbott Q3 2026 Earnings

Adj EPS $1.42, Est. $1.42 Net Sales $13.01B, Est. $13B Comparable Sales +7% Sees Q4 Adj EPS $1.62—$1.67 Reaffirms FY EPS Guidance Plans to Separate Global Nutrition Business Into Public Company by End-2027 Daniel Salvadori to Become CEO of New Nutrition Company Separation Through Tax-Free Distribution to Shareholders Separation Won't Impact 2026 or 2027 Guidance Expects One-Time Charges Related to Transaction

ABT
SquawkNews Desk 3 updates Updated Oct 21, 2026, 11:56 AM UTC

Story updates

11:33:24 AM UTC
SquawkNews
Abbott Labs 3Q Comparable Sales Rose 7% >ABT
11:41:26 AM UTC
SquawkNews
Abbott's Q3 revenue slightly beats estimates, reaffirms adjusted EPS guidance
11:56:13 AM UTC
SquawkNews
By Connor HartAbbott plans to separate its nutrition business into an independent company with about $8.5 billion in annual sales.Daniel Salvadori, who currently serves as executive vice president and group president of Abbott's established pharmaceuticals and nutritional products division, will le…

Adj EPS $1.42, Est. $1.42 Net Sales $13.01B, Est. $13B Comparable Sales +7% Sees Q4 Adj EPS $1.62—$1.67 Reaffirms FY EPS Guidance Plans to Separate Global Nutrition Business Into Public Company by End-2027 Daniel Salvadori to Become CEO of New Nutrition Company Separation Through Tax-Free Distribution to Shareholders Separation Won't Impact 2026 or 2027 Guidance Expects One-Time Charges Related to Transaction